KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Steris (STE) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $840.7 million.

  • Steris' Cost of Revenue rose 1058.93% to $840.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 666.91%. This contributed to the annual value of $3.1 billion for FY2025, which is 466.39% up from last year.
  • According to the latest figures from Q4 2025, Steris' Cost of Revenue is $840.7 million, which was up 1058.93% from $814.4 million recorded in Q3 2025.
  • Steris' 5-year Cost of Revenue high stood at $840.7 million for Q4 2025, and its period low was $493.7 million during Q1 2021.
  • Over the past 5 years, Steris' median Cost of Revenue value was $711.9 million (recorded in 2021), while the average stood at $700.7 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 6818.81% in 2021, then plummeted by 1507.23% in 2022.
  • Steris' Cost of Revenue (Quarter) stood at $670.9 million in 2021, then decreased by 5.46% to $634.2 million in 2022, then increased by 16.31% to $737.7 million in 2023, then rose by 3.05% to $760.2 million in 2024, then increased by 10.59% to $840.7 million in 2025.
  • Its Cost of Revenue stands at $840.7 million for Q4 2025, versus $814.4 million for Q3 2025 and $763.1 million for Q2 2025.